Protective effects of vanoxeamine (GBR12909) against ischaemia-induced hyperactivity and neurodegeneration in the gerbil model of cerebral ischaemia
Maginn M, Kelly JP, Leonard BE. Protective effects of vanoxeamine (GBR12909) against ischaemia-induced hyperactivity and neurodegeneration in the gerbil model of cerebral ischaemia. Pharmacol Biochem Behav 1997; 56: 727-35.
A specific inhibitor of calcium/calmodulin-dependent protein kinase- II provides neuroprotection against NMDA- and hypoxia/hypoglycemia-induced cell death
Hajimohammadreza I, Probert AW, Coughenour LL, Borosky SA, Marcoux FW, Boxer PA, et al. A specific inhibitor of calcium/calmodulin-dependent protein kinase- II provides neuroprotection against NMDA- and hypoxia/hypoglycemia-induced cell death. J Neurosci 1995; 15: 4093-101.
Kinetic analysis of the phosphorylation-dependent interactions of synapsin I with rat brain synaptic vesicles
Stefani G, Onofri F, Valtorta F, Vaccaro P, Greengard P, Benfenati F. Kinetic analysis of the phosphorylation-dependent interactions of synapsin I with rat brain synaptic vesicles. J Physiol (Lond) 1997; 504: 501-15.
Identification of a phosphorylation site for calcium/calmodulin-dependent protein kinase II in the NR2B subunit of the N-methyl-D-aspartate receptor
Omkumar RV, Kiely MJ, Rosenstein AJ, Min KT, Kennedy MB. Identification of a phosphorylation site for calcium/calmodulin-dependent protein kinase II in the NR2B subunit of the N-methyl-D-aspartate receptor. J Biol Chem 1996 ; 271: 31670-8.
Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-K II during long-term potentiation
Barria A, Muller D, Derkach V, Griffith LC, Soderling TR. Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-K II during long-term potentiation. Science 1997; 276: 2012-5.
Presynaptic modulation of cortical synaptic activity by calcineurin
Victor RG, Thomas GD, Marban E, O'Rourke B. Presynaptic modulation of cortical synaptic activity by calcineurin. Proc Natl Acad Sci USA 1995; 92: 6269-73.